Research has found that middle-aged individuals in their forties and fifties with elevated cortisol levels, a hormone associated with stress, perform worse on cognitive and memory tasks compared to individuals of the same age who have average levels of cortisol. Elevated blood cortisol levels were also linked to smaller brain volumes. One factor that’s getting… Read More »
At the age of 17, my younger sister Elisabeth noticed a change in her body — enlargement of the front of her neck. “I just thought I was building muscle from working out,” she innocently rationalized. A series of laboratory tests and imaging followed and led to a much more grave discovery — cancer. There… Read More »
FDA Approves Udenyca (pegfilgrastim-cbqv), a Biosimilar to Neulasta Print this page REDWOOD CITY, Calif., Nov. 02, 2018 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (NASDAQ: CHRS), today announced that the U.S. Food and Drug Administration (FDA) has approved Udenyca (pegfilgrastim-cbqv), the first pegfilgrastim biosimilar approved by both the FDA and the European Commission (EC) for patients… Read More »
You’ve heard of mindfulness, but what is it, really? How is it different from meditation? Is mindfulness really helpful? Is it hokey? And can you learn it? Do you need to go to a week-long camp or a psychotherapist or a guru? The answer could be on your smartphone. What is mindfulness? There’s no specific… Read More »
Late in the afternoon on Thursday, Nov. 1, the federal Centers for Medicare & Medicaid Services (CMS) published a final rule that provides updates to the Physician Fee Schedule and calendar-year 2019 Quality Payment Program (QPP), which encapsulates the Medicare Incentive-based Payment Program (MIPS) and Advanced Payment Models In the proposed rule, which was released… Read More »